<bill session="108" type="hc" number="314" updated="2023-01-15T07:17:55Z">
  <state datetime="2003-10-29">REFERRED</state>
  <status>
    <introduced datetime="2003-10-29"/>
  </status>
  <introduced datetime="2003-10-29"/>
  <titles>
    <title type="display">Expressing the sense of Congress regarding women with bleeding disorders.</title>
    <title type="official" as="introduced">Expressing the sense of Congress regarding women with bleeding disorders.</title>
  </titles>
  <sponsor bioguide_id="M000309"/>
  <cosponsors>
    <cosponsor bioguide_id="B000490" joined="2003-11-04"/>
    <cosponsor bioguide_id="B001245" joined="2004-04-02"/>
    <cosponsor bioguide_id="B000911" joined="2004-04-20"/>
    <cosponsor bioguide_id="C000191" joined="2003-10-29"/>
    <cosponsor bioguide_id="C000380" joined="2003-10-29"/>
    <cosponsor bioguide_id="C001049" joined="2004-03-23"/>
    <cosponsor bioguide_id="C000794" joined="2004-03-30"/>
    <cosponsor bioguide_id="C000984" joined="2004-03-17"/>
    <cosponsor bioguide_id="D000168" joined="2004-03-23"/>
    <cosponsor bioguide_id="D000482" joined="2004-03-17"/>
    <cosponsor bioguide_id="G000551" joined="2004-03-17"/>
    <cosponsor bioguide_id="I000057" joined="2003-11-17"/>
    <cosponsor bioguide_id="K000113" joined="2004-03-11"/>
    <cosponsor bioguide_id="L000551" joined="2003-10-29"/>
    <cosponsor bioguide_id="L000287" joined="2004-03-10"/>
    <cosponsor bioguide_id="L000554" joined="2004-03-09"/>
    <cosponsor bioguide_id="M001145" joined="2004-03-23"/>
    <cosponsor bioguide_id="M001142" joined="2004-03-17"/>
    <cosponsor bioguide_id="M000316" joined="2003-10-29"/>
    <cosponsor bioguide_id="M000590" joined="2003-11-17"/>
    <cosponsor bioguide_id="M000714" joined="2003-10-29"/>
    <cosponsor bioguide_id="N000179" joined="2004-03-25"/>
    <cosponsor bioguide_id="N000147" joined="2003-10-29"/>
    <cosponsor bioguide_id="O000085" joined="2004-03-11"/>
    <cosponsor bioguide_id="P000149" joined="2003-11-17"/>
    <cosponsor bioguide_id="R000576" joined="2004-06-14"/>
    <cosponsor bioguide_id="S001157" joined="2004-03-23"/>
    <cosponsor bioguide_id="T000193" joined="2004-03-30"/>
    <cosponsor bioguide_id="V000128" joined="2004-06-02"/>
    <cosponsor bioguide_id="W000215" joined="2004-03-09"/>
    <cosponsor bioguide_id="W000314" joined="2004-02-24"/>
    <cosponsor bioguide_id="W000784" joined="2003-11-04"/>
  </cosponsors>
  <actions>
    <action datetime="2003-10-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-10-29" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2003-11-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Blood diseases"/>
    <term name="Child health"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Genetic counseling"/>
    <term name="Health education"/>
    <term name="Hemophilia"/>
    <term name="Hormones"/>
    <term name="Hysterectomy"/>
    <term name="Medical research"/>
    <term name="Medical screening"/>
    <term name="Medical tests"/>
    <term name="Menstruation"/>
    <term name="Preventive medicine"/>
    <term name="Science, Technology, Communications"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary date="2003-11-06T19:56:44Z" status="Introduced in House">Expresses the sense of Congress that: (1) the Federal Government has a responsibility to further research on von Willebrand's disease, improve access to treatment centers for all individuals with bleeding disorders, and increase funding for research; (2) the Director of the National Institutes of Health should develop a 5-year research plan concerning women with bleeding disorders; (3) the Director of the Centers for Disease Control and Prevention should continue to improve outreach, treatment, and prevention of the complications of women's bleeding disorders; (4) physicians should screen all adolescents and all adult women presenting with severe menorrhagia for von Willebrand's disease; (5) hysterectomy for excessive menstrual bleeding should not be performed without the consideration of a bleeding disorder; (6) referral of women with bleeding disorders to a federally sponsored hemophilia treatment center is critical to comprehensive treatment; (7) physicians should be encouraged to conduct clotting factor assays for carrier diagnosis and to facilitate genotyping of the disorder and patients should be referred for genetic counseling when appropriate; and (8) patient advocate organizations and medical specialty societies should continue to collaborate on public education campaigns to educate women about bleeding disorders.</summary>
</bill>
